189 related articles for article (PubMed ID: 21291118)
1. The importance of bone biomarkers in the diagnosis of renal osteodystrophy.
Pena YT; Soyibo AK; McGrowder D; Clarke TR; Barton EN
West Indian Med J; 2010 Jun; 59(3):332-7. PubMed ID: 21291118
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic accuracy study comparing total alkaline phosphatase with intact parathyroid hormone 1-84 for the diagnosis of high turnover renal osteodystrophy in chronic renal failure on hemodialysis].
Rojas González AM; Opazo Valenzuela M; Muñoz Navarro S
Medwave; 2014 Sep; 14(8):e6014. PubMed ID: 25340338
[TBL] [Abstract][Full Text] [Related]
3. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A
Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371
[TBL] [Abstract][Full Text] [Related]
4. Profile of chronic kidney disease related-mineral bone disorders in newly diagnosed advanced predialysis diabetic kidney disease patients: A hospital based cross-sectional study.
Ray S; Beatrice AM; Ghosh A; Pramanik S; Bhattacharjee R; Ghosh S; Raychaudhury A; Mukhopadhyay S; Chowdhury S
Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S931-S937. PubMed ID: 28728874
[TBL] [Abstract][Full Text] [Related]
5. Bone Biopsy Results in Chronic Kidney Disease: a Single-Center Experience.
Liangos O; Kirchhoff S; Buchholz J; Ketteler M
Kidney Blood Press Res; 2018; 43(4):1222-1230. PubMed ID: 30071519
[TBL] [Abstract][Full Text] [Related]
6. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH
Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
Sprague SM; Bellorin-Font E; Jorgetti V; Carvalho AB; Malluche HH; Ferreira A; D'Haese PC; Drüeke TB; Du H; Manley T; Rojas E; Moe SM
Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
[TBL] [Abstract][Full Text] [Related]
9. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.
Coen G; Ballanti P; Bonucci E; Calabria S; Centorrino M; Fassino V; Manni M; Mantella D; Mazzaferro S; Napoletano I; Sardella D; Taggi F
Nephrol Dial Transplant; 1998 Sep; 13(9):2294-302. PubMed ID: 9761512
[TBL] [Abstract][Full Text] [Related]
10. Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease.
Doumouchtsis K; Perrea D; Doumouchtsis S; Tziamalis M; Poulakou M; Vlachos I; Kostakis A
Ther Apher Dial; 2009 Feb; 13(1):49-55. PubMed ID: 19379170
[TBL] [Abstract][Full Text] [Related]
11. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology.
Fletcher S; Jones RG; Rayner HC; Harnden P; Hordon LD; Aaron JE; Oldroyd B; Brownjohn AM; Turney JH; Smith MA
Nephron; 1997; 75(4):412-9. PubMed ID: 9127327
[TBL] [Abstract][Full Text] [Related]
12. The five most commonly used intact parathyroid hormone assays are useful for screening but not for diagnosing bone turnover abnormalities in CKD-5 patients.
Herberth J; Monier-Faugere MC; Mawad HW; Branscum AJ; Herberth Z; Wang G; Cantor T; Malluche HH
Clin Nephrol; 2009 Jul; 72(1):5-14. PubMed ID: 19640382
[TBL] [Abstract][Full Text] [Related]
13. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients.
Bervoets AR; Spasovski GB; Behets GJ; Dams G; Polenakovic MH; Zafirovska K; Van Hoof VO; De Broe ME; D'Haese PC
Am J Kidney Dis; 2003 May; 41(5):997-1007. PubMed ID: 12722034
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy.
Salam S; Gallagher O; Gossiel F; Paggiosi M; Khwaja A; Eastell R
J Am Soc Nephrol; 2018 May; 29(5):1557-1565. PubMed ID: 29555831
[No Abstract] [Full Text] [Related]
15. Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers
.
Lima F; Mawad H; El-Husseini AA; Davenport DL; Malluche HH
Clin Nephrol; 2019 Apr; 91(4):222-230. PubMed ID: 30862350
[TBL] [Abstract][Full Text] [Related]
16. Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease Stages 3 - 5.
Lehmann G; Ott U; Kaemmerer D; Schuetze J; Wolf G
Clin Nephrol; 2008 Oct; 70(4):296-305. PubMed ID: 18826854
[TBL] [Abstract][Full Text] [Related]
17. Alkaline Phosphatase, iPTH and Bone Turnover Markers in Chinese Advanced Chronic Kidney Disease Patients.
Liu Y; He Q
Clin Lab; 2015; 61(7):839-43. PubMed ID: 26299086
[TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients.
Haas M; Leko-Mohr Z; Roschger P; Kletzmayr J; Schwarz C; Domenig C; Zsontsich T; Klaushofer K; Delling G; Oberbauer R
Am J Kidney Dis; 2002 Mar; 39(3):580-6. PubMed ID: 11877577
[TBL] [Abstract][Full Text] [Related]
19. A new approach for evaluating bone turnover in chronic kidney disease.
Tolouian R; Hernandez GT; Chiang WY; Gupta A
Eur J Intern Med; 2010 Jun; 21(3):230-2. PubMed ID: 20493428
[TBL] [Abstract][Full Text] [Related]
20. [Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis].
Nowak Z; Konieczna M; Wańkowicz Z
Pol Merkur Lekarski; 2004 Aug; 17(98):138-41. PubMed ID: 15603322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
